Alzheimer Disease & Dementia
09.21.24
Copy Link
Like
In this series, Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses cerebrospinal fluid, PET, and blood-based biomarker tests for Alzheimer disease, including factors influencing the selection of these tests and recommendations for physicians when communicating test results with their patients. In this episode, Dr. Schindler discusses key factors physicians should consider when ordering a biomarker test and recommendations for how physicians should communicate the need for a particular test with their patients.
Sign up to receive alerts and updates from The Neurology Hub.
Thanks for subscribing
Do you have cases, images, or other information to share? The Neurology Hub welcomes submissions from clinicians and researchers at all levels.
Contribute Here